BIM
BIOL

BlackRock Investment Management’s Biolase, Inc. BIOL Stock Holding History

BlackRock Investment Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Hold
0
– – – 3631
2016
Q3 		– Hold
0
– – – 3567
2016
Q2 		– Sell
-1
Closed -$15.8K – 3776
2016
Q1 		$11K Hold
1
– – ﹤0.01% 3582
2015
Q4 		$8K Hold
1
– – ﹤0.01% 3761
2015
Q3 		$7K Hold
1
– – ﹤0.01% 3833
2015
Q2 		$14K Buy
+1
New +$24.4K ﹤0.01% 3593
2015
Q1 		– Hold
0
– – – 3627
2014
Q4 		– Hold
0
– – – 3560
2014
Q3 		– Hold
0
– – – 3569
2014
Q2 		– Sell
-8
Closed -$204K – 3608
2014
Q1 		$241K Hold
8
– – ﹤0.01% 3211
2013
Q4 		$269K Hold
8
– – ﹤0.01% 3174
2013
Q3 		$180K Buy
8
+1
+14% +$32.2K ﹤0.01% 3200
2013
Q2 		$300K Buy
+7
New +$391K ﹤0.01% 3085

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Investment Management's BIOL Position: Q4 2016 in Review

BlackRock Investment Management held its Biolase, Inc. (BIOL) position steady in Q4 2016 at 0 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3631.

BlackRock Investment Management first reported a position in BIOL in Q2 2013 and has held it in 8 quarters since. The position peaked at $300K in Q2 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q4 2016.

  • BlackRock Investment Management held 0 shares of Biolase, Inc. worth $9K as of Q4 2016.
  • BlackRock Investment Management left its Biolase, Inc. share count unchanged in Q4 2016.
  • Biolase, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3631 holding.
  • BlackRock Investment Management first reported a position in Biolase, Inc. in Q2 2013 and has held it in 8 quarters since.
  • BlackRock Investment Management's Biolase, Inc. position peaked at $300K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.